These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3094463)

  • 21. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
    Williams HJ; Ward JR; Egger MJ; Reading JC; Samuelson CO; Altz-Smith M; Willkens RW; Solsky MA; Hayes SP; Furst D
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():39-50. PubMed ID: 6432412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of auranofin: a review of clinical experience.
    Blodgett RC; Pietrusko RG
    Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auranofin-induced vasomotor reaction.
    Proudman SM; Cleland LG
    Arthritis Rheum; 1992 Dec; 35(12):1452-4. PubMed ID: 1472122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate.
    Brückle W; Dexel T; Grasedyck K; Schattenkirchner M
    Clin Rheumatol; 1994 Jun; 13(2):209-16. PubMed ID: 8088061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P; Landon M
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract]   [Full Text] [Related]  

  • 28. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R; Tvede N; Bendixen G
    Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
    [No Abstract]   [Full Text] [Related]  

  • 31. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis.
    Pedersen BK; Abom B
    Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 33. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
    Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scarring alopecia following gold therapy.
    Burrows NP; Grant JW; Crisp AJ; Roberts SO
    Acta Derm Venereol; 1994 Nov; 74(6):486. PubMed ID: 7701895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy.
    Crilly A; Madhok R; Watson J; Capell HA; Sturrock RD
    Br J Rheumatol; 1994 Sep; 33(9):821-5. PubMed ID: 7915945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis.
    Palit J; Hill J; Capell HA; Carey J; Daunt SO; Cawley MI; Bird HA; Nuki G
    Br J Rheumatol; 1990 Aug; 29(4):280-3. PubMed ID: 2116206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.
    Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT
    Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open comparative study of auranofin vs. gold sodium thiomalate.
    Smith PR; Brown GM; Meyers OL
    J Rheumatol Suppl; 1982; 8():190-6. PubMed ID: 6813484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.